Rebecca Brachman Headshot
Report a problem with this profile
[email protected]

Rebecca Brachman  

Neurocientist & Entrepreneur, Pioneering the Field of Preventative Psychopharmacology

Rebecca Brachman is a neuroscientist, TED Fellow, and NYCEDC Entrepreneurship Lab Fellow pioneering the field of preventative psychopharmacology. She and her colleagues aim to create drugs that enhance psychological resilience against stress and prevent mental illness.

Current treatments for mood disorders only suppress symptoms without addressing the underlying disease, and there are no known cures. The drugs Dr. Brachman is developing would be the first to prevent psychiatric disorders such as post-traumatic stress disorder (PTSD) and depression.

Dr. Brachman is co-founder and director of the Social Outcomes Initiative—a social impact organization that repurposes generic drugs for the treatment of PTSD, traumatic brain injury, and other unmet medical needs—and co-founder and Chief Scientific Officer at Sunrise—a mission-driven initiative to cure, treat, and prevent depression.

Brachman obtained her PhD in Neuroscience from Columbia University, prior to which she was a fellow at the National Institutes of Health, where she discovered that immune cells carry a memory of psychological stress and that white blood cells can act as antidepressants and resilience-enhancers. She is a TED Fellow, Jacobs Technion-Cornell Runway Fellow, NYCEDC Entrepreneurship Lab Fellow, and member of the Helena Brain Trust. Brachman's research has been featured in The Atlantic, WIRED and Business Insider, and her work was recently described by Dr. George Slavich on NPR as a "moonshot project that is very much needed in the mental health arena."

Brachman is also a playwright and screenwriter and previously served as the director of NeuWrite, a national network of science-writing groups that fosters ongoing collaboration between scientists, writers, and artists.

News


Helena project to incentivize generic drug repurposing - Business ...

Several years ago, the neuroscientist and entrepreneur Rebecca Brachman made an accidental discovery that she thought could be a game-changer for ...

Meet the 34-year-old neuroscientist developing a drug to prevent depression and PTSD

VANCOUVER — For soldiers going to war or aid workers sent to disaster areas, the stress of their exposure to trauma can trigger serious depression and suicidal ideation. But imagine if before they left, or even as they were there, they could take a drug that would prevent the onset of future mental illness?

Preventing Mental Illness With a Stress Vaccine

Influenced by a school shooting, a neuroscientist is on a mission to change how both the brain and immune system handle stress.

Related Speakers View all


More like Rebecca